Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
STML > SEC Filings for STML > Form 8-K on 29-Mar-2013All Recent SEC Filings

Show all filings for STEMLINE THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for STEMLINE THERAPEUTICS INC


29-Mar-2013

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective March 25, 2013, Mr. Kenneth Hoberman was appointed as the Chief Operating Officer of Stemline Therapeutics, Inc. ("Stemline").

Kenneth Hoberman, age 48, has served as Stemline's Vice President of Operations since March 2012. From 2004 to 2012, Mr. Hoberman was Vice President of Corporate and Business Development of Keryx Biopharmaceuticals, Inc., where he was instrumental in securing multiple sources of capital including over $200 million in equity investments through public and private offerings. He also initiated and executed a $100 million strategic alliance and originated, negotiated and closed dozens of licensing and operational contracts, and helped grow the company to a $900 million market capitalization at its peak. Previously, he was Managing Director at Hawkins BioVentures, a healthcare advisory firm. Mr. Hoberman received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University.

No family relationships exist between Mr. Hoberman and any of our directors or other executive officers. There are no arrangements between Mr. Hoberman and any other person pursuant to which Mr. Hoberman was selected as an officer, nor are there any transactions to which Stemline is or was a participant and in which Mr. Hoberman has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

The terms of Mr. Hoberman's employment are being finalized and will be set forth in an employment agreement with Stemline.


  Add STML to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for STML - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.